Aiyo, that "new form" business is how companies try to extend patents on old medicines by making small changes, which is that evergreening! The Glivec judgment by our Supreme Court rightly stopped this, saying salt forms like imatinib mesylate are not truly new. That is why I, a CML patient, can afford generic imatinib today. If not for that judgment, the loan I took for my son's fees would instead be for my own survival.
#athletics#track-and-field
Jump in to reply — no account needed.